| Literature DB >> 26816656 |
Cen Chen1, Huafeng Han1, Wei Yang1, Xiaoyuan Ren1, Xiangdong Kong1.
Abstract
In this study, calcium carbonate (CaCO3) nanoparticles with spherical structure were regulated by arginine and successfully synthesized via a facile co-precipitation method. The average particle size of as-prepared CaCO3 was about 900 nm. The properties of nanostructured CaCO3 particles were characterized by scanning electron microscope, Fourier transform infrared spectroscopy, X-ray diffraction and size distribution. After modified with polyethyleneimine (PEI), the ability of PEI-CaCO3 nanoparticles to carry GFP-marked p53 gene (pEGFP-C1-p53) into cancer cells to express P53 protein were studied. Meanwhile, the cytotoxicity, transfection efficiency, cells growth inhibition and the ability to induce apoptosis by expressed P53 protein were conducted to evaluate the performances of PEI-CaCO3 nanoparticles. The results show that prepared PEI-CaCO3 nanoparticles had good biocompatibility and low cytotoxicity in a certain concentration range. PEI-CaCO3 effectively transfected pEGFP-C1 gene into epithelial-like cancer cells. And with the expression of GFP-P53 fusion protein, pEGFP-C1-p53-gene-loaded PEI-CaCO3 particles significantly reduced the proliferation of cancer cells. These findings indicate that our PEI-modified CaCO3 nanoparticles are potential to be successfully used as carriers for gene therapy.Entities:
Keywords: calcium carbonate; gene therapy; nanoparticles; p53; polyethyleneimine
Year: 2016 PMID: 26816656 PMCID: PMC4723273 DOI: 10.1093/rb/rbv029
Source DB: PubMed Journal: Regen Biomater ISSN: 2056-3426
Figure 1. (a) SEM image, (b) Size distribution, (c) XRD pattern and (d) FTIR spectrum of ACa nanoparticles
Figure 2. Cell cytotoxicity of QSG-7701 cells treated with different concentrations of ACa NPs at 24 h. The percentage of cells viability was calculated relative to untreated cells and presented as the mean ± standard deviation (n = 6). *P < 0.05 and **P < 0.01
Figure 3. Fluorescence images of different cell lines treated with pEGFP-C1-p53 or PEI-ACa-pEGFP-C1-p53. The images were taken at 24 h, 48 h and 72 h, respectively. Scale bars represent 200 μm
Figure 4. (a) GFP-P53 protein expression from different groups identified by western blotting. (b) Growth inhibition of H1299 cells treated with pEGFP-C1-p53, PEI-ACa and PEI-ACa- pEGFP-C1-p53 at 24 h, 48 h and 72 h. The percentage of cells viability was calculated relative to untreated cells and presented as the mean ± standard deviation (n = 6). *P < 0.05
Figure 5. Apoptosis images of different cells transfected by pEGFP-C1-p53 and PEI-ACa- pEGFP-C1-p53. The nuclear of cells was stained with Hoechst 33342 nuclear stain at 72 h and observed under fluorescence microscope. The arrows indicated the apoptosis cells